Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Yu Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3990-0308; OpenAlex author ID A5100613659. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 2 papers · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 2 papers

Papers 10

  1. Cancer-Associated Fibroblasts Foster a High-Lactate Microenvironment to Drive Perineural Invasion in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-24-3173↗
  2. Combining genetic and non-genetic factors to predict the risk of pancreatic cancer in patients with new-onset diabetes mellitus. Co-author DOI 10.1186/s12916-025-04048-4↗
  3. Extracellular vesicle-packaged PIAT from cancer-associated fibroblasts drives neural remodeling by mediating m5C modification in pancreatic cancer mouse models. Co-author DOI 10.1126/scitranslmed.adi0178↗
  4. Association of genetic risk and lifestyle with pancreatic cancer and their age dependency: a large prospective cohort study in the UK Biobank. Co-author DOI 10.1186/s12916-023-03202-0↗
  5. Leveraging Tumor Microenvironment Infiltration in Pancreatic Cancer to Identify Gene Signatures Related to Prognosis and Immunotherapy Response. Co-author DOI 10.3390/cancers15051442↗
  6. [Current status and challenges of accurate preoperative assessment of pancreatic cancer]. Co-author DOI 10.3760/cma.j.cn112139-20210701-00284↗
  7. Revision of Surgical Margin under Frozen Section to Achieve R0 Status on Survival in Patients with Pancreatic Cancer. First author DOI 10.1007/s11605-018-3806-x↗
  8. Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused by pancreatic ductal adenocarcinoma. First author DOI 10.1007/s00125-014-3481-8↗
  9. Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis. Co-author DOI 10.1097/md.0000000000001345↗
  10. Pancreatic stellate cells promotes the perineural invasion in pancreatic cancer. Co-author DOI 10.1016/j.mehy.2012.03.017↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Liangtang Zeng · 3 shared papers, 2023–2025 · strength 0.80
  2. Rufu Chen · 3 shared papers, 2023–2025 · strength 0.80
  3. Zhuo Kui Wu · 3 shared papers, 2023–2025 · strength 0.80
  4. Shangyou Zheng · 3 shared papers, 2015–2025 · strength 0.45
  5. Jiabin Yang · 2 shared papers, 2023 · strength 0.43
  6. Chengyuan Hu · 2 shared papers, 2024–2025 · strength 0.41
  7. Rufu Chen · 2 shared papers, 2024–2025 · strength 0.41
  8. Rihua He · 2 shared papers, 2024–2025 · strength 0.41
  9. Min Yu · 3 shared papers, 2015–2023 · strength 0.32
  10. R F Chen · 1 shared paper, 2022 · strength 0.26
  11. Changhao Chen · 2 shared papers, 2015–2024 · strength 0.24
  12. Chonghui Hu · 1 shared paper, 2025 · strength 0.22
  13. Yuan Yuan · 1 shared paper, 2025 · strength 0.22
  14. Huimou Chen · 1 shared paper, 2025 · strength 0.22
  15. Leyi Huang · 1 shared paper, 2023 · strength 0.19
  16. Tianhao Huang · 1 shared paper, 2024 · strength 0.19
  17. Guolin Li · 1 shared paper, 2024 · strength 0.19
  18. Xiang Zhang · 1 shared paper, 2024 · strength 0.19
  19. Rufu Chen · 3 shared papers, 2012–2015 · strength 0.14
  20. Yimin Liu · 2 shared papers, 2015 · strength 0.09
  21. Quanbo Zhou · 2 shared papers, 2012–2015 · strength 0.09
  22. Chuanzhao Zhang · 1 shared paper, 2018 · strength 0.09
  23. Zhixiang Jian · 1 shared paper, 2018 · strength 0.09
  24. Zi Yin · 1 shared paper, 2018 · strength 0.09
  25. Baohua Hou · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.